Featured news

Inadequate investment and funding for tuberculosis (TB) control in Africa is jeopardizing the efforts to meet the global target of ending the disease by 2030, while the COVID-19 pandemic threatens to roll back progress made so far in the continent, an assessment by World Health Organization (WHO) finds.

With new COVID-19 cases significantly dropping, many countries are increasingly curtailing COVID-19 surveillance and quarantine measures. While the need to reopen economies and resume social life is important, the World Health Organization (WHO) is calling for caution and consideration of the risks involved. 

Harare – Nothando Moyo* contemplated giving up treatment for multidrug-resistant tuberculosis “even if it meant I would die,” she admits. The months-long treatment for the drug-resistant strain—which does not respond to the two most effective drugs—entailed daily injections which Moyo, a resident of Zimbabwe’s Bulawayo city, found painful to bear.

Hundreds of farmers in Migori County, Kenya will break free from risky tobacco farming and transition to producing more sustainable crops, through the Tobacco-Free Farms Project being launched today. 

Abidjan – When Cote d’Ivoire set to drive up COVID-19 uptake, a three-week mass vaccination campaign in February saw over 2 million people vaccinated, yielding an 8% rise in the number of people fully vaccinated. In a country with less than 20% vaccine coverage, the increase realized in a matter of weeks marks a significant progress.

Seychelles is stepping up genomic surveillance to investigate outbreaks and track disease variants to better understand diseases transmission and inform decisions. A joint mission of the World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) is in the country to support this effort by building in-country capacity for genomic surveillance.